Structure

Physi-Chem Properties

Molecular Weight:  584.17
Volume:  537.424
LogP:  0.251
LogD:  -0.133
LogS:  -1.177
# Rotatable Bonds:  10
TPSA:  242.13
# H-Bond Aceptor:  15
# H-Bond Donor:  8
# Rings:  4
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.089
Synthetic Accessibility Score:  5.091
Fsp3:  0.538
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.608
MDCK Permeability:  9.81375269475393e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.691
Human Intestinal Absorption (HIA):  0.935
20% Bioavailability (F20%):  0.484
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.216
Plasma Protein Binding (PPB):  52.15800094604492%
Volume Distribution (VD):  0.34
Pgp-substrate:  41.08122253417969%

ADMET: Metabolism

CYP1A2-inhibitor:  0.066
CYP1A2-substrate:  0.041
CYP2C19-inhibitor:  0.02
CYP2C19-substrate:  0.059
CYP2C9-inhibitor:  0.005
CYP2C9-substrate:  0.097
CYP2D6-inhibitor:  0.01
CYP2D6-substrate:  0.125
CYP3A4-inhibitor:  0.035
CYP3A4-substrate:  0.04

ADMET: Excretion

Clearance (CL):  1.605
Half-life (T1/2):  0.973

ADMET: Toxicity

hERG Blockers:  0.037
Human Hepatotoxicity (H-HT):  0.15
Drug-inuced Liver Injury (DILI):  0.729
AMES Toxicity:  0.092
Rat Oral Acute Toxicity:  0.051
Maximum Recommended Daily Dose:  0.009
Skin Sensitization:  0.22
Carcinogencity:  0.266
Eye Corrosion:  0.003
Eye Irritation:  0.02
Respiratory Toxicity:  0.435

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475484

Natural Product ID:  NPC475484
Common Name*:   Arbortristoside B
IUPAC Name:   methyl (1S,4aS,5S,6R,7S,7aS)-6-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-5-hydroxy-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
Synonyms:  
Standard InCHIKey:  PSFREQJZNFIHKK-OKPJLNDISA-N
Standard InCHI:  InChI=1S/C26H32O15/c1-37-24(36)12-9-38-25(41-26-22(35)21(34)19(32)15(8-28)39-26)18-11(7-27)23(20(33)17(12)18)40-16(31)5-3-10-2-4-13(29)14(30)6-10/h2-6,9,11,15,17-23,25-30,32-35H,7-8H2,1H3/b5-3+/t11-,15-,17-,18-,19-,20+,21+,22-,23-,25+,26+/m1/s1
SMILES:  OC[C@H]1[C@@H](OC(=O)/C=C/c2ccc(c(c2)O)O)[C@H]([C@H]2[C@@H]1[C@@H](OC=C2C(=O)OC)O[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL506451
PubChem CID:   44576088
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0004081] Iridoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33172 nyctanthes arbortristis Species Oleaceae Eukaryota n.a. n.a. n.a. PMID[1791475]
NPO33172 nyctanthes arbortristis Species Oleaceae Eukaryota n.a. n.a. n.a. PMID[22608855]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT71 Cell Line HEK293 Homo sapiens Activity = 54.83 % PMID[548377]
NPT71 Cell Line HEK293 Homo sapiens Activity = 93.62 % PMID[548377]
NPT6376 Individual Protein Trypanothione reductase Leishmania donovani Inhibition = 46.87 % PMID[548377]
NPT6376 Individual Protein Trypanothione reductase Leishmania donovani Inhibition = 67.87 % PMID[548377]
NPT6376 Individual Protein Trypanothione reductase Leishmania donovani Inhibition = 77.53 % PMID[548377]
NPT6376 Individual Protein Trypanothione reductase Leishmania donovani Inhibition = 96.88 % PMID[548377]
NPT6376 Individual Protein Trypanothione reductase Leishmania donovani Inhibition = 41.87 % PMID[548377]
NPT6376 Individual Protein Trypanothione reductase Leishmania donovani Inhibition = 63.63 % PMID[548377]
NPT6376 Individual Protein Trypanothione reductase Leishmania donovani Inhibition = 92.58 % PMID[548377]
NPT633 Organism Leishmania donovani Leishmania donovani Inhibition = 28.13 % PMID[548376]
NPT633 Organism Leishmania donovani Leishmania donovani Inhibition = 41.74 % PMID[548376]
NPT633 Organism Leishmania donovani Leishmania donovani Inhibition = 25.12 % PMID[548376]
NPT633 Organism Leishmania donovani Leishmania donovani Inhibition = 47.34 % PMID[548376]
NPT633 Organism Leishmania donovani Leishmania donovani Survival = 59.0 day PMID[548376]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 = 7630.0 nM PMID[548377]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 = 3504.0 nM PMID[548377]
NPT633 Organism Leishmania donovani Leishmania donovani Activity = 2.96 % PMID[548377]
NPT633 Organism Leishmania donovani Leishmania donovani Activity = 13.52 % PMID[548377]
NPT633 Organism Leishmania donovani Leishmania donovani Activity = 31.04 % PMID[548377]
NPT633 Organism Leishmania donovani Leishmania donovani Activity = 52.48 % PMID[548377]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475484 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9592 High Similarity NPC96599
0.9539 High Similarity NPC179914
0.9396 High Similarity NPC117346
0.9396 High Similarity NPC240592
0.9355 High Similarity NPC145847
0.9295 High Similarity NPC109990
0.9252 High Similarity NPC296659
0.9252 High Similarity NPC202391
0.9226 High Similarity NPC138993
0.9205 High Similarity NPC475379
0.9122 High Similarity NPC251062
0.9122 High Similarity NPC184464
0.9108 High Similarity NPC476011
0.9097 High Similarity NPC187205
0.9079 High Similarity NPC158546
0.9079 High Similarity NPC289021
0.9062 High Similarity NPC21956
0.9057 High Similarity NPC130730
0.9057 High Similarity NPC301910
0.9054 High Similarity NPC186296
0.9032 High Similarity NPC475378
0.902 High Similarity NPC203664
0.9013 High Similarity NPC69367
0.8986 High Similarity NPC296643
0.8981 High Similarity NPC474936
0.894 High Similarity NPC18789
0.8919 High Similarity NPC137501
0.8919 High Similarity NPC7518
0.8919 High Similarity NPC154262
0.8919 High Similarity NPC159387
0.8868 High Similarity NPC206815
0.8831 High Similarity NPC269914
0.8831 High Similarity NPC478249
0.8824 High Similarity NPC478234
0.8824 High Similarity NPC478236
0.8797 High Similarity NPC469384
0.879 High Similarity NPC478248
0.8784 High Similarity NPC31745
0.8784 High Similarity NPC220936
0.8774 High Similarity NPC194705
0.8766 High Similarity NPC147224
0.8734 High Similarity NPC49173
0.8734 High Similarity NPC286919
0.8734 High Similarity NPC475663
0.8718 High Similarity NPC229354
0.8718 High Similarity NPC89693
0.8718 High Similarity NPC229548
0.8718 High Similarity NPC478241
0.8704 High Similarity NPC282551
0.8658 High Similarity NPC49597
0.8654 High Similarity NPC478235
0.8636 High Similarity NPC23677
0.8636 High Similarity NPC308178
0.8627 High Similarity NPC475539
0.8627 High Similarity NPC473147
0.8627 High Similarity NPC119773
0.8627 High Similarity NPC473867
0.8627 High Similarity NPC143246
0.8627 High Similarity NPC474268
0.8618 High Similarity NPC77922
0.8618 High Similarity NPC473281
0.8618 High Similarity NPC194938
0.8616 High Similarity NPC104275
0.8616 High Similarity NPC4747
0.8616 High Similarity NPC226759
0.8608 High Similarity NPC156624
0.8608 High Similarity NPC172920
0.8599 High Similarity NPC245615
0.8599 High Similarity NPC115466
0.8599 High Similarity NPC299706
0.8599 High Similarity NPC61604
0.8581 High Similarity NPC478242
0.8562 High Similarity NPC76211
0.8562 High Similarity NPC475528
0.8553 High Similarity NPC475213
0.8553 High Similarity NPC152796
0.8553 High Similarity NPC293154
0.8544 High Similarity NPC478232
0.8543 High Similarity NPC46644
0.8533 High Similarity NPC220942
0.8528 High Similarity NPC180586
0.8526 High Similarity NPC35097
0.8526 High Similarity NPC12006
0.8516 High Similarity NPC120728
0.8514 High Similarity NPC169398
0.8509 High Similarity NPC478265
0.8506 High Similarity NPC212808
0.8497 Intermediate Similarity NPC63304
0.8494 Intermediate Similarity NPC470685
0.8491 Intermediate Similarity NPC38699
0.8481 Intermediate Similarity NPC44730
0.8471 Intermediate Similarity NPC140151
0.8467 Intermediate Similarity NPC302583
0.8467 Intermediate Similarity NPC100558
0.8467 Intermediate Similarity NPC84789
0.8467 Intermediate Similarity NPC310252
0.8452 Intermediate Similarity NPC473149
0.8446 Intermediate Similarity NPC470143
0.8446 Intermediate Similarity NPC322503
0.8438 Intermediate Similarity NPC471405
0.8438 Intermediate Similarity NPC163635
0.8431 Intermediate Similarity NPC116104
0.8431 Intermediate Similarity NPC263397
0.8431 Intermediate Similarity NPC237872
0.8431 Intermediate Similarity NPC302286
0.8431 Intermediate Similarity NPC88754
0.8428 Intermediate Similarity NPC191046
0.8428 Intermediate Similarity NPC327032
0.8428 Intermediate Similarity NPC194095
0.8428 Intermediate Similarity NPC472128
0.8428 Intermediate Similarity NPC472127
0.8411 Intermediate Similarity NPC321184
0.8411 Intermediate Similarity NPC321638
0.8411 Intermediate Similarity NPC171134
0.8411 Intermediate Similarity NPC472350
0.8411 Intermediate Similarity NPC197316
0.8411 Intermediate Similarity NPC89105
0.8411 Intermediate Similarity NPC328273
0.8411 Intermediate Similarity NPC81515
0.8411 Intermediate Similarity NPC64141
0.8411 Intermediate Similarity NPC476383
0.8411 Intermediate Similarity NPC68092
0.8408 Intermediate Similarity NPC229882
0.8408 Intermediate Similarity NPC158635
0.84 Intermediate Similarity NPC470572
0.8397 Intermediate Similarity NPC28776
0.8397 Intermediate Similarity NPC473138
0.8395 Intermediate Similarity NPC130489
0.8395 Intermediate Similarity NPC208676
0.8389 Intermediate Similarity NPC287597
0.8389 Intermediate Similarity NPC886
0.8389 Intermediate Similarity NPC471883
0.8389 Intermediate Similarity NPC34293
0.8385 Intermediate Similarity NPC472860
0.8378 Intermediate Similarity NPC473285
0.8375 Intermediate Similarity NPC10205
0.8366 Intermediate Similarity NPC477277
0.8366 Intermediate Similarity NPC477278
0.8365 Intermediate Similarity NPC157898
0.8365 Intermediate Similarity NPC257847
0.8365 Intermediate Similarity NPC87403
0.8354 Intermediate Similarity NPC474620
0.8354 Intermediate Similarity NPC100420
0.8344 Intermediate Similarity NPC65262
0.8344 Intermediate Similarity NPC92117
0.8344 Intermediate Similarity NPC469364
0.8344 Intermediate Similarity NPC260425
0.8344 Intermediate Similarity NPC161955
0.8344 Intermediate Similarity NPC476376
0.8344 Intermediate Similarity NPC101686
0.8343 Intermediate Similarity NPC475299
0.8333 Intermediate Similarity NPC316539
0.8333 Intermediate Similarity NPC123988
0.8333 Intermediate Similarity NPC476870
0.8323 Intermediate Similarity NPC478055
0.8323 Intermediate Similarity NPC10945
0.8323 Intermediate Similarity NPC108455
0.8323 Intermediate Similarity NPC210330
0.8323 Intermediate Similarity NPC228357
0.8322 Intermediate Similarity NPC254398
0.8313 Intermediate Similarity NPC208818
0.8313 Intermediate Similarity NPC476364
0.8311 Intermediate Similarity NPC254819
0.8311 Intermediate Similarity NPC219677
0.8303 Intermediate Similarity NPC475738
0.8302 Intermediate Similarity NPC478268
0.8302 Intermediate Similarity NPC36130
0.8302 Intermediate Similarity NPC106818
0.8302 Intermediate Similarity NPC134905
0.8301 Intermediate Similarity NPC134405
0.8301 Intermediate Similarity NPC9218
0.8301 Intermediate Similarity NPC477279
0.8301 Intermediate Similarity NPC476385
0.8301 Intermediate Similarity NPC476377
0.8301 Intermediate Similarity NPC47471
0.8299 Intermediate Similarity NPC477293
0.8299 Intermediate Similarity NPC229784
0.8299 Intermediate Similarity NPC477294
0.8293 Intermediate Similarity NPC41009
0.8291 Intermediate Similarity NPC205054
0.8289 Intermediate Similarity NPC205195
0.8284 Intermediate Similarity NPC171706
0.8282 Intermediate Similarity NPC239966
0.8282 Intermediate Similarity NPC203020
0.828 Intermediate Similarity NPC120621
0.828 Intermediate Similarity NPC248257
0.8272 Intermediate Similarity NPC133984
0.8269 Intermediate Similarity NPC474234
0.8269 Intermediate Similarity NPC37838
0.8266 Intermediate Similarity NPC299855
0.8266 Intermediate Similarity NPC96194
0.8261 Intermediate Similarity NPC131532
0.8258 Intermediate Similarity NPC196063
0.8258 Intermediate Similarity NPC141455
0.8258 Intermediate Similarity NPC296954
0.8258 Intermediate Similarity NPC478240
0.8258 Intermediate Similarity NPC229036
0.8258 Intermediate Similarity NPC300894
0.8255 Intermediate Similarity NPC473924
0.825 Intermediate Similarity NPC137813

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475484 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8896 High Similarity NPD7685 Pre-registration
0.8411 Intermediate Similarity NPD7266 Discontinued
0.8077 Intermediate Similarity NPD6190 Approved
0.8035 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD7228 Approved
0.7882 Intermediate Similarity NPD3818 Discontinued
0.7798 Intermediate Similarity NPD7199 Phase 2
0.7784 Intermediate Similarity NPD6234 Discontinued
0.775 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD7054 Approved
0.7697 Intermediate Similarity NPD37 Approved
0.7688 Intermediate Similarity NPD7472 Approved
0.7688 Intermediate Similarity NPD7074 Phase 3
0.7669 Intermediate Similarity NPD1653 Approved
0.7665 Intermediate Similarity NPD4966 Approved
0.7665 Intermediate Similarity NPD4967 Phase 2
0.7665 Intermediate Similarity NPD4965 Approved
0.7665 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7657 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD230 Phase 1
0.7602 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD7251 Discontinued
0.7543 Intermediate Similarity NPD6797 Phase 2
0.7515 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD8127 Discontinued
0.7458 Intermediate Similarity NPD7808 Phase 3
0.7453 Intermediate Similarity NPD8166 Discontinued
0.7401 Intermediate Similarity NPD7240 Approved
0.7394 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD4628 Phase 3
0.7342 Intermediate Similarity NPD6653 Approved
0.7325 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD1934 Approved
0.7262 Intermediate Similarity NPD7028 Phase 2
0.7261 Intermediate Similarity NPD6663 Approved
0.7247 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD8455 Phase 2
0.7232 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD5736 Approved
0.7222 Intermediate Similarity NPD8312 Approved
0.7222 Intermediate Similarity NPD8313 Approved
0.7213 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD6559 Discontinued
0.7175 Intermediate Similarity NPD7799 Discontinued
0.716 Intermediate Similarity NPD4380 Phase 2
0.7159 Intermediate Similarity NPD6166 Phase 2
0.7159 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD2801 Approved
0.7135 Intermediate Similarity NPD1465 Phase 2
0.7135 Intermediate Similarity NPD5844 Phase 1
0.7119 Intermediate Similarity NPD7473 Discontinued
0.711 Intermediate Similarity NPD7075 Discontinued
0.7093 Intermediate Similarity NPD3817 Phase 2
0.709 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD6355 Discontinued
0.7055 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD6005 Phase 3
0.7055 Intermediate Similarity NPD5763 Approved
0.7055 Intermediate Similarity NPD6002 Phase 3
0.7055 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD5762 Approved
0.7055 Intermediate Similarity NPD6004 Phase 3
0.7052 Intermediate Similarity NPD3882 Suspended
0.7051 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD5647 Approved
0.7045 Intermediate Similarity NPD6232 Discontinued
0.7031 Intermediate Similarity NPD7680 Approved
0.703 Intermediate Similarity NPD4110 Phase 3
0.703 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD3027 Phase 3
0.7024 Intermediate Similarity NPD6273 Approved
0.702 Intermediate Similarity NPD9545 Approved
0.7013 Intermediate Similarity NPD9269 Phase 2
0.7006 Intermediate Similarity NPD9494 Approved
0.7 Intermediate Similarity NPD7458 Discontinued
0.7 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD3620 Phase 2
0.6995 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6987 Remote Similarity NPD3094 Phase 2
0.6981 Remote Similarity NPD3764 Approved
0.697 Remote Similarity NPD6674 Discontinued
0.6936 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6936 Remote Similarity NPD7819 Suspended
0.6933 Remote Similarity NPD7033 Discontinued
0.6932 Remote Similarity NPD5494 Approved
0.6928 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6919 Remote Similarity NPD8150 Discontinued
0.6909 Remote Similarity NPD970 Clinical (unspecified phase)
0.6905 Remote Similarity NPD1511 Approved
0.6897 Remote Similarity NPD5353 Approved
0.6894 Remote Similarity NPD1613 Approved
0.6894 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6889 Remote Similarity NPD3751 Discontinued
0.6879 Remote Similarity NPD6801 Discontinued
0.6871 Remote Similarity NPD7097 Phase 1
0.6864 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6859 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6856 Remote Similarity NPD7435 Discontinued
0.6845 Remote Similarity NPD7236 Approved
0.6839 Remote Similarity NPD3705 Approved
0.6839 Remote Similarity NPD3092 Approved
0.6828 Remote Similarity NPD8434 Phase 2
0.6826 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6824 Remote Similarity NPD1512 Approved
0.6821 Remote Similarity NPD6385 Approved
0.6821 Remote Similarity NPD6386 Approved
0.6821 Remote Similarity NPD8320 Phase 1
0.6821 Remote Similarity NPD8319 Approved
0.6802 Remote Similarity NPD3455 Phase 2
0.68 Remote Similarity NPD5402 Approved
0.6795 Remote Similarity NPD1608 Approved
0.6792 Remote Similarity NPD2861 Phase 2
0.679 Remote Similarity NPD4140 Approved
0.679 Remote Similarity NPD943 Approved
0.6772 Remote Similarity NPD6362 Approved
0.677 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6769 Remote Similarity NPD7497 Discontinued
0.6768 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6768 Remote Similarity NPD8151 Discontinued
0.6766 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6766 Remote Similarity NPD7930 Approved
0.6765 Remote Similarity NPD2533 Approved
0.6765 Remote Similarity NPD2532 Approved
0.6765 Remote Similarity NPD2534 Approved
0.676 Remote Similarity NPD3787 Discontinued
0.6753 Remote Similarity NPD9268 Approved
0.6748 Remote Similarity NPD5735 Approved
0.6744 Remote Similarity NPD7239 Suspended
0.6743 Remote Similarity NPD5761 Phase 2
0.6743 Remote Similarity NPD5760 Phase 2
0.6731 Remote Similarity NPD1091 Approved
0.6728 Remote Similarity NPD6233 Phase 2
0.6705 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6702 Remote Similarity NPD6534 Approved
0.6702 Remote Similarity NPD6535 Approved
0.6701 Remote Similarity NPD6777 Approved
0.6701 Remote Similarity NPD7999 Approved
0.6701 Remote Similarity NPD6781 Approved
0.6701 Remote Similarity NPD6779 Approved
0.6701 Remote Similarity NPD6780 Approved
0.6701 Remote Similarity NPD6778 Approved
0.6701 Remote Similarity NPD6776 Approved
0.6701 Remote Similarity NPD6782 Approved
0.6687 Remote Similarity NPD826 Approved
0.6687 Remote Similarity NPD825 Approved
0.6687 Remote Similarity NPD2935 Discontinued
0.6684 Remote Similarity NPD7296 Approved
0.6684 Remote Similarity NPD7700 Phase 2
0.6684 Remote Similarity NPD7699 Phase 2
0.6667 Remote Similarity NPD3268 Approved
0.6667 Remote Similarity NPD2797 Approved
0.6667 Remote Similarity NPD6798 Discontinued
0.6667 Remote Similarity NPD7422 Clinical (unspecified phase)
0.665 Remote Similarity NPD7874 Approved
0.665 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6646 Remote Similarity NPD447 Suspended
0.6646 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6645 Remote Similarity NPD1357 Approved
0.6644 Remote Similarity NPD3022 Approved
0.6644 Remote Similarity NPD3021 Approved
0.663 Remote Similarity NPD5242 Approved
0.6629 Remote Similarity NPD7411 Suspended
0.6627 Remote Similarity NPD651 Clinical (unspecified phase)
0.6627 Remote Similarity NPD1510 Phase 2
0.6627 Remote Similarity NPD3750 Approved
0.6617 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6617 Remote Similarity NPD7783 Phase 2
0.6608 Remote Similarity NPD6799 Approved
0.6607 Remote Similarity NPD1549 Phase 2
0.6605 Remote Similarity NPD7095 Approved
0.6603 Remote Similarity NPD17 Approved
0.6603 Remote Similarity NPD3019 Approved
0.6603 Remote Similarity NPD2932 Approved
0.6599 Remote Similarity NPD7696 Phase 3
0.6599 Remote Similarity NPD7697 Approved
0.6599 Remote Similarity NPD7698 Approved
0.659 Remote Similarity NPD5403 Approved
0.6587 Remote Similarity NPD2438 Suspended
0.6587 Remote Similarity NPD9570 Approved
0.6587 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6587 Remote Similarity NPD6099 Approved
0.6587 Remote Similarity NPD6100 Approved
0.6585 Remote Similarity NPD4060 Phase 1
0.6584 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6581 Remote Similarity NPD3091 Approved
0.6576 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6575 Remote Similarity NPD7229 Phase 3
0.6571 Remote Similarity NPD6599 Discontinued
0.657 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6568 Remote Similarity NPD1652 Phase 2
0.6566 Remote Similarity NPD7870 Phase 2
0.6566 Remote Similarity NPD7871 Phase 2
0.6562 Remote Similarity NPD6213 Phase 3
0.6562 Remote Similarity NPD6212 Phase 3
0.6562 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6559 Remote Similarity NPD6765 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data